Chronic oral administration of fenretinide, as a chemopreventive agent to breast cancer patients, does not affect plasma alpha-tocopherol concentration.
Formelli
F
F
Clerici
M
M
De Palo
G
G
Costa
A
A
Veronesi
U
U
D000284:Administration, Oral; D000328:Adult; D001943:Breast Neoplasms / Q000097:blood / Q000517:prevention & control*; D005260:Female; D017313:Fenretinide; D006801:Humans; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D014212:Tretinoin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014810:Vitamin E / Q000097:blood
D014810:Vitamin E; D017313:Fenretinide; D014212:Tretinoin